• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路感染中的宿主-病原体相互作用。

Host-pathogen interactions in urinary tract infection.

机构信息

Department of Microbiology and Immunology, University of Michigan Medical School, 5641 Medical Science Building II, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0620, USA.

出版信息

Nat Rev Urol. 2010 Aug;7(8):430-41. doi: 10.1038/nrurol.2010.101. Epub 2010 Jul 20.

DOI:10.1038/nrurol.2010.101
PMID:20647992
Abstract

The urinary tract is a common site of bacterial infections; nearly half of all women experience at least one urinary tract infection (UTI) during their lifetime. These infections are classified based on the condition of the host. Uncomplicated infections affect otherwise healthy individuals and are most commonly caused by uropathogenic Escherichia coli, whereas complicated infections affect patients with underlying difficulties, such as a urinary tract abnormality or catheterization, and are commonly caused by species such as Proteus mirabilis. Virulence and fitness factors produced by both pathogens include fimbriae, toxins, flagella, iron acquisition systems, and proteins that function in immune evasion. Additional factors that contribute to infection include the formation of intracellular bacterial communities by E. coli and the production of urease by P. mirabilis, which can result in urinary stone formation. Innate immune responses are induced or mediated by pattern recognition receptors, antimicrobial peptides, and neutrophils. The adaptive immune response to UTI is less well understood. Host factors TLR4 and CXCR1 are implicated in disease outcome and susceptibility, respectively. Low levels of TLR4 are associated with asymptomatic bacteriuria while low levels of CXCR1 are associated with increased incidence of acute pyelonephritis. Current research is focused on the identification of additional virulence factors and therapeutic or prophylactic targets that might be used in the generation of vaccines against both uropathogens.

摘要

尿路是细菌感染的常见部位;几乎一半的女性在其一生中至少会经历一次尿路感染(UTI)。这些感染根据宿主的情况进行分类。非复杂性感染影响健康个体,最常见的病原体是尿路致病性大肠杆菌,而复杂性感染影响存在潜在困难的患者,如尿路异常或导管插入,常见病原体如奇异变形杆菌。两种病原体产生的毒力和适应性因素包括菌毛、毒素、鞭毛、铁获取系统以及在免疫逃避中发挥作用的蛋白质。有助于感染的其他因素包括大肠杆菌形成细胞内细菌群落和奇异变形杆菌产生脲酶,这可能导致尿路结石形成。先天免疫反应由模式识别受体、抗菌肽和中性粒细胞诱导或介导。对 UTI 的适应性免疫反应了解较少。宿主因素 TLR4 和 CXCR1 分别与疾病结局和易感性有关。TLR4 水平低与无症状菌尿有关,而 CXCR1 水平低与急性肾盂肾炎的发生率增加有关。目前的研究集中在鉴定其他毒力因子和治疗或预防靶点,这些可能用于开发针对尿路病原体的疫苗。

相似文献

1
Host-pathogen interactions in urinary tract infection.尿路感染中的宿主-病原体相互作用。
Nat Rev Urol. 2010 Aug;7(8):430-41. doi: 10.1038/nrurol.2010.101. Epub 2010 Jul 20.
2
[Virulence factors and host responses in urinary tract infections].[尿路感染中的毒力因子与宿主反应]
J UOEH. 1998 Mar 1;20(1):45-60. doi: 10.7888/juoeh.20.45.
3
Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis.尿路致病性大肠杆菌和奇异变形杆菌的毒力决定因素。
Kidney Int Suppl. 1994 Nov;47:S129-36.
4
Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold.奇异变形杆菌中参与尿路感染发病机制的基因:25个标签诱变突变体的鉴定,其毒力至少减弱100倍。
Infect Immun. 2004 May;72(5):2922-38. doi: 10.1128/IAI.72.5.2922-2938.2004.
5
Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections.易感性急性肾盂肾炎或无症状菌尿症:尿路感染中的宿主-病原体相互作用。
Pediatr Nephrol. 2012 Nov;27(11):2017-2029. doi: 10.1007/s00467-011-2089-1. Epub 2012 Feb 12.
6
Proteus mirabilis and Urinary Tract Infections.奇异变形杆菌与尿路感染。
Microbiol Spectr. 2015 Oct;3(5). doi: 10.1128/microbiolspec.UTI-0017-2013.
7
The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.奇异变形杆菌的致病潜力在多微生物性尿路感染期间会被其他尿路病原体增强。
Infect Immun. 2017 Jan 26;85(2). doi: 10.1128/IAI.00808-16. Print 2017 Feb.
8
Virulence factors of uropathogenic E. coli and their interaction with the host.尿路致病性大肠杆菌的毒力因子及其与宿主的相互作用。
Adv Microb Physiol. 2014;65:337-72. doi: 10.1016/bs.ampbs.2014.08.006. Epub 2014 Nov 4.
9
Vaccines for Proteus mirabilis in urinary tract infection.用于尿路感染的奇异变形杆菌疫苗。
Int J Antimicrob Agents. 2002 Jun;19(6):461-5. doi: 10.1016/s0924-8579(02)00102-4.
10
TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.Toll样受体(TLR)和CXC趋化因子受体1(CXCR1)依赖性固有免疫:对尿路感染遗传学的见解
Eur J Clin Invest. 2008 Oct;38 Suppl 2:12-20. doi: 10.1111/j.1365-2362.2008.02004.x.

引用本文的文献

1
Roles of Pho regulon in bacterial pathogenicity.Pho 调控子在细菌致病性中的作用。
Virulence. 2025 Dec;16(1):2545559. doi: 10.1080/21505594.2025.2545559. Epub 2025 Aug 13.
2
Stem cell-derived exosomes in complicated urinary tract infections: immunomodulatory mechanisms and potential therapeutic strategies for urothelial repair.干细胞衍生的外泌体在复杂性尿路感染中的作用:免疫调节机制及尿路上皮修复的潜在治疗策略
Stem Cell Res Ther. 2025 Aug 5;16(1):422. doi: 10.1186/s13287-025-04548-3.
3
Fosfomycin resistance in extended-spectrum beta-lactamase producing isolated from urinary tract-infected patients in a tertiary care hospital.

本文引用的文献

1
Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.锌摄取有助于运动,并为奇异变形杆菌在实验性尿路感染期间提供竞争优势。
Infect Immun. 2010 Jun;78(6):2823-33. doi: 10.1128/IAI.01220-09. Epub 2010 Apr 12.
2
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.成人导管相关泌尿道感染的诊断、预防和治疗:美国传染病学会 2009 年国际临床实践指南。
Clin Infect Dis. 2010 Mar 1;50(5):625-63. doi: 10.1086/650482.
3
在一家三级护理医院中,从尿路感染患者分离出的产超广谱β-内酰胺酶菌株中的磷霉素耐药性。
J Med Microbiol. 2025 Jul;74(7). doi: 10.1099/jmm.0.002039.
4
Distribution of Fimbrial Genes and Their Association with Virulence and Levofloxacin Resistance/Extended-Spectrum Beta-Lactamase Production in Uropathogenic .尿道致病性大肠杆菌中菌毛基因的分布及其与毒力和左氧氟沙星耐药性/超广谱β-内酰胺酶产生的关联
Antibiotics (Basel). 2025 May 6;14(5):468. doi: 10.3390/antibiotics14050468.
5
Harnessing intracellular bacteria in bladder by intravesical delivery of antibiotics-loaded nanodiamonds to reduce the recurrence of urinary tract infection.通过膀胱内递送载有抗生素的纳米金刚石来利用膀胱内的细胞内细菌,以减少尿路感染的复发。
J Nanobiotechnology. 2025 May 21;23(1):367. doi: 10.1186/s12951-025-03459-y.
6
Different factors control long-term versus short-term outcomes for bacterial colonisation of a urinary catheter.不同因素控制着导尿管细菌定植的长期和短期结果。
Nat Commun. 2025 Apr 26;16(1):3940. doi: 10.1038/s41467-025-59161-y.
7
Anti-inflammatory drugs as potential antimicrobial agents: a review.抗炎药物作为潜在抗菌剂的综述
Front Pharmacol. 2025 Apr 8;16:1557333. doi: 10.3389/fphar.2025.1557333. eCollection 2025.
8
Characterization and therapeutic potential of phage vB_Eco_ZCEC08 against multidrug-resistant uropathogenic Escherichia coli.噬菌体vB_Eco_ZCEC08对多重耐药性尿路致病性大肠杆菌的特性及治疗潜力
BMC Microbiol. 2025 Apr 16;25(1):221. doi: 10.1186/s12866-025-03903-x.
9
Patient-reported therapeutic benefits of herbal medicinal products in the treatment of gynecological ailments.患者报告的草药产品在治疗妇科疾病中的治疗益处。
BMC Complement Med Ther. 2025 Mar 11;25(1):99. doi: 10.1186/s12906-025-04761-w.
10
Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli.用于研究致病性大肠杆菌引起的细胞内细菌群落发育的犬膀胱上皮细胞模型。
PLoS One. 2025 Jan 9;20(1):e0316834. doi: 10.1371/journal.pone.0316834. eCollection 2025.
The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection.
尿路致病性大肠埃希菌引起的固有免疫应答涉及到在尿路感染的小鼠模型中白细胞介素-17A。
J Immunol. 2010 Feb 15;184(4):2065-75. doi: 10.4049/jimmunol.0902386. Epub 2010 Jan 18.
4
Waging war against uropathogenic Escherichia coli: winning back the urinary tract.与尿路致病性大肠杆菌作斗争:夺回尿路。
Infect Immun. 2010 Feb;78(2):568-85. doi: 10.1128/IAI.01000-09. Epub 2009 Nov 16.
5
Mucosal immunization with iron receptor antigens protects against urinary tract infection.用铁受体抗原进行黏膜免疫可预防尿路感染。
PLoS Pathog. 2009 Sep;5(9):e1000586. doi: 10.1371/journal.ppat.1000586. Epub 2009 Sep 18.
6
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB.尿路致病性大肠杆菌通过毒力岛基因sisA和sisB抑制宿主炎症反应。
Infect Immun. 2009 Dec;77(12):5322-33. doi: 10.1128/IAI.00779-09. Epub 2009 Sep 21.
7
An "omics" approach to uropathogenic Escherichia coli vaccinology.一种针对尿路致病性大肠杆菌疫苗学的“组学”方法。
Trends Microbiol. 2009 Oct;17(10):431-2. doi: 10.1016/j.tim.2009.07.003. Epub 2009 Sep 14.
8
Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements.鉴定一种模块化致病岛,其在产脲酶尿路致病菌中广泛存在,并与多种移动元件具有共同特征。
Infect Immun. 2009 Nov;77(11):4887-94. doi: 10.1128/IAI.00705-09. Epub 2009 Aug 17.
9
Uroplakins in urothelial biology, function, and disease.尿路上皮生物学、功能及疾病中的尿血小板溶素
Kidney Int. 2009 Jun;75(11):1153-1165. doi: 10.1038/ki.2009.73. Epub 2009 Apr 1.
10
Tamm-horsfall protein protects against urinary tract infection by proteus mirabilis.Tamm-Horsfall蛋白可抵御奇异变形杆菌引起的尿路感染。
J Urol. 2009 May;181(5):2332-8. doi: 10.1016/j.juro.2009.01.014. Epub 2009 Mar 19.